English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/201743
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis

AuthorsCarella, Antonella; Tejedor, Juan Ramón; García, María G.; Urdinguio, Rocío G.; Bayón, Gustavo F.; Sierra, Marta I.; López, Virginia; García-Toraño, Estela; Santamarina-Ojeda, Pablo; Pérez, Raúl F.; Bigot, Timothée; Mangas, Cristina; Corte-Torres, M. Daniela; Sáenz-de-Santa-María, Inés; Mollejo, Manuela; Meléndez, Bárbara; Astudillo, Aurora; Chiara, María-Dolores; Fernández, Agustín F.; Fraga, Mario F.
KeywordsDNA methylation
TET3
Glioma
Methylation arrays
Issue Date2019
PublisherInternational Union against Cancer
John Wiley & Sons
CitationInternational Journal of Cancer 146(2): 373-387 (2019)
AbstractLoss of 5‐hydroxymethylcytosine (5hmC) has been associated with mutations of the ten–eleven translocation (TET) enzymes in several types of cancer. However, tumors with wild‐type TET genes can also display low 5hmC levels, suggesting that other mechanisms involved in gene regulation might be implicated in the decline of this epigenetic mark. Here we show that DNA hypermethylation and loss of DNA hydroxymethylation, as well as a marked reduction of activating histone marks in the TET3 gene, impair TET3 expression and lead to a genome‐wide reduction in 5hmC levels in glioma samples and cancer cell lines. Epigenetic drugs increased expression of TET3 in glioblastoma cells and ectopic overexpression of TET3 impaired in vitro cell growth and markedly reduced tumor formation in immunodeficient mice models. TET3 overexpression partially restored the genome‐wide patterns of 5hmC characteristic of control brain samples in glioblastoma cell lines, while elevated TET3 mRNA levels were correlated with better prognosis in glioma samples. Our results suggest that epigenetic repression of TET3 might promote glioblastoma tumorigenesis through the genome‐wide alteration of 5hmC.
Publisher version (URL)https://doi.org/10.1002/ijc.32520
URIhttp://hdl.handle.net/10261/201743
DOIhttp://dx.doi.org/10.1002/ijc.32520
ISSN0020-7136
E-ISSN1097-0215
Appears in Collections:(CINN) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf59,24 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.